LABS — Medipharm Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapTurnaround

Annual balance sheet for Medipharm Labs, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	38.6	19.9	34.1	24.1	18
Net Total Accounts Receivable
Net Total Receivables	27.5	34.1	16.9	13	5.87
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	120	81.5	65.5	47.3	36.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42.2	34.1	25.9	18.1	25.3
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	169	118	92.4	65.5	63.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.8	24.2	8.88	9.46	10.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	37.3	39.8	9.21	9.49	10.9
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	132	78.4	83.1	56	53
Total Liabilities & Shareholders' Equity	169	118	92.4	65.5	63.9
Total Common Shares Outstanding